{ "schema": "picoportal.search-run-provenance/1", "exportedAt": "2026-10-29T13:21:35.310Z", "tool": { "name": "PICO search builder", "database": "PubMed via NCBI E-utilities", "vocabulary": "NLM MeSH via id.nlm.nih.gov" }, "aiUse": { "modelsServed": [], "statement": "No generative AI model was used: the strategy was supplied by the searcher and checked with the PICO search builder. Every MeSH heading, Supplementary Concept and publication type was looked up in NLM MeSH (id.nlm.nih.gov): 1 valid. Every line was run in PubMed through NCBI E-utilities on October 28, 2026, and its count compared with the count written in the strategy." }, "run": { "id": "8e431d77-f4f5-4c57-aec7-f84165e0baeb", "kind": "validate", "status": "done", "stage": "saving", "question": null, "input": { "text": "1 | \"Diabetes Mellitus, Type 2\"[Mesh] | \n2 | semaglutide[tiab] | \n3 | 1 AND 2 | " }, "strategy": null, "lines": [ { "no": 1, "kind": "raw", "refs": [], "count": 204451, "query": "\"Diabetes Mellitus, Type 2\"[Mesh]", "issues": [], "display": "\"Diabetes Mellitus, Type 2\"[Mesh]", "countedAt": "2026-10-28T18:00:07.299Z", "vocabulary": [ { "tag": "Mesh", "kind": "descriptor", "label": "Diabetes Mellitus, Type 2", "quoted": true, "validation": { "ui": "D003924", "label": "Diabetes Mellitus, Type 2", "status": "valid" } } ], "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms]", "quotedPhrasesNotFound": [] }, "reportedCount": null }, { "no": 2, "kind": "raw", "refs": [], "count": 5792, "query": "semaglutide[tiab]", "issues": [], "display": "semaglutide[tiab]", "countedAt": "2026-10-28T18:02:58.002Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"semaglutide\"[Title/Abstract]", "quotedPhrasesNotFound": [] }, "reportedCount": null }, { "no": 3, "kind": "raw", "refs": [ 1, 2 ], "count": 1740, "query": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (semaglutide[tiab])", "issues": [], "display": "1 AND 2", "countedAt": "2026-10-28T18:02:57.690Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms] AND \"semaglutide\"[Title/Abstract]", "quotedPhrasesNotFound": [] }, "reportedCount": null } ], "finalQuery": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (semaglutide[tiab])", "finalCount": 1740, "issues": [], "recall": null, "seeds": null, "reference": null, "records": [ { "pmid": "42947001", "year": "2026", "title": "Comparison of cardiac adverse event signal profiles for GLP-1 receptor agonists: an analysis of the FAERS database.", "authors": "Yildirim BO, Sarkim IF, Yalman G et al.", "journal": "BMC cardiovascular disorders", "publicationTypes": [ "Journal Article", "Comparative Study" ] }, { "pmid": "42946127", "year": "2026", "title": "Semaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance.", "authors": "Melamed B, Parsi-Zahabi M, Omrani MA et al.", "journal": "Pharmacoepidemiology and drug safety", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42937793", "year": "2026", "title": "Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): A systematic review and meta-analysis.", "authors": "Alfawaz M, Bajamaan D, Alghamdi L et al.", "journal": "Medicine", "publicationTypes": [ "Journal Article", "Systematic Review", "Meta-Analysis" ] }, { "pmid": "42918905", "year": "2026", "title": "GLP-1-based therapies in cardiovascular disease: outcomes, mechanisms, and emerging clinical applications.", "authors": "Jang R, Jang M, Ruan X et al.", "journal": "European journal of clinical pharmacology", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42905300", "year": "2026", "title": "Decoding the Safety Profile of GLP-1 Receptor Agonists: Facts, Myths, and Ongoing Controversies.", "authors": "Kounatidis DC, Vallianou NG, Kouveletsou M et al.", "journal": "Current obesity reports", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42899606", "year": "2026", "title": "Effectiveness of Weekly Semaglutide Treatment (0.5 or 1 mg) in Chilean Patients with Type 2 Diabetes Mellitus.", "authors": "Estica M, Godoy G, Vargas C et al.", "journal": "Revista medica de Chile", "publicationTypes": [ "Journal Article", "Multicenter Study", "Clinical Trial, Phase IV" ] }, { "pmid": "42890523", "year": "2026", "title": "CagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis.", "authors": "Rasool ZK, Shah R, Batool AEZ et al.", "journal": "Frontiers in endocrinology", "publicationTypes": [ "Journal Article", "Systematic Review", "Meta-Analysis" ] }, { "pmid": "42886550", "year": "2026", "title": "Pharmacy students' knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study.", "authors": "Khojah AA, Gazzaz MJ, Aldurdunji MM et al.", "journal": "The Libyan journal of medicine", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42885796", "year": "2026", "title": "Glucagon-Like Peptide-1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity.", "authors": "Governor SB, Dávila-García DM, Rivera-Segarra E et al.", "journal": "Journal of the American Heart Association", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42866418", "year": "2026", "title": "Values, preferences, and treatment burden for initiation of GLP-1 receptor agonists, SGLT-2 inhibitors, tirzepatide, and finerenone in adults with type 2 diabetes: systematic review.", "authors": "González-Cruz DC, Garcia-Campa M, Moreno-Peña PJ et al.", "journal": "BMJ medicine", "publicationTypes": [ "Journal Article", "Systematic Review" ] }, { "pmid": "42865361", "year": "2026", "title": "Pancreatic and biliary safety signals of GLP-1 receptor agonists and tirzepatide: a disproportionality analysis of FAERS reports.", "authors": "Wu Y, Li K, Wang Y et al.", "journal": "Frontiers in endocrinology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42859665", "year": "2026", "title": "Severe Euglycemic Diabetic Ketoacidosis After Semaglutide-Associated Poor Intake Despite Empagliflozin Discontinuation: A Case Report.", "authors": "Niknam K, Niknam T", "journal": "International medical case reports journal", "publicationTypes": [ "Case Reports", "Journal Article" ] }, { "pmid": "42854065", "year": "2026", "title": "Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease.", "authors": "Gong C, Luo Q, Li Q", "journal": "Medicine", "publicationTypes": [ "Journal Article", "Observational Study" ] }, { "pmid": "42827168", "year": "2026", "title": "Comorbid Cardiovascular-Liver Disease Disparities: Current Understanding and Future Directions.", "authors": "Hafez A, Nour M, Ibrahim R et al.", "journal": "Current cardiology reports", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42824923", "year": "2026", "title": "Predictors of treatment response to semaglutide for weight management.", "authors": "Tzoulis P", "journal": "Frontiers in endocrinology", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42823110", "year": "2026", "title": "Tirzepatide safety in EudraVigilance: descriptive and disproportionality analysis of preferred terms related to suboptimal treatment outcomes and drug-use-related issues.", "authors": "Popa Ilie IR, Ghibu S, Butuca A et al.", "journal": "BMJ open", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42808923", "year": "2026", "title": "Gastrointestinal adverse effects of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists: A narrative expert review of approved therapies, oral formulations, and pipeline agents.", "authors": "Singhani V, Ehsan M, Valencia S et al.", "journal": "Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42808550", "year": "2026", "title": "Real-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes.", "authors": "Hoog MM, Vallarino C, Maldonado JM et al.", "journal": "Journal of managed care & specialty pharmacy", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42802824", "year": "2026", "title": "Dapagliflozin Alone or Combined With Semaglutide: Cardiovascular and Renal Outcomes Among Patients With Type 2 Diabetes Mellitus in a 6-Month Real-World Retrospective Cohort Study in Saudi Arabia.", "authors": "Alharajin R, AlTaweel M, AlSubaiee M et al.", "journal": "Journal of the ASEAN Federation of Endocrine Societies", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42796421", "year": "2026", "title": "Clinical Profile of Documented Diabetic Peripheral Neuropathy by GLP-1-Based Medication Status: A Cross-Sectional Study.", "authors": "Ferician AC, Ghitea TC, Popoviciu MS", "journal": "Medicina (Kaunas, Lithuania)", "publicationTypes": [ "Journal Article" ] } ], "error": null, "createdAt": "2026-10-28T18:02:57.506Z", "finishedAt": "2026-10-28T18:03:00.784Z", "versionNo": 1 }, "versions": [ { "versionNo": 1, "createdBy": "import", "strategy": null, "lines": [ { "no": 1, "kind": "raw", "refs": [], "count": 204451, "query": "\"Diabetes Mellitus, Type 2\"[Mesh]", "issues": [], "display": "\"Diabetes Mellitus, Type 2\"[Mesh]", "countedAt": "2026-10-28T18:00:07.299Z", "vocabulary": [ { "tag": "Mesh", "kind": "descriptor", "label": "Diabetes Mellitus, Type 2", "quoted": true, "validation": { "ui": "D003924", "label": "Diabetes Mellitus, Type 2", "status": "valid" } } ], "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms]", "quotedPhrasesNotFound": [] }, "reportedCount": null }, { "no": 2, "kind": "raw", "refs": [], "count": 5792, "query": "semaglutide[tiab]", "issues": [], "display": "semaglutide[tiab]", "countedAt": "2026-10-28T18:02:58.002Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"semaglutide\"[Title/Abstract]", "quotedPhrasesNotFound": [] }, "reportedCount": null }, { "no": 3, "kind": "raw", "refs": [ 1, 2 ], "count": 1740, "query": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (semaglutide[tiab])", "issues": [], "display": "1 AND 2", "countedAt": "2026-10-28T18:02:57.690Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms] AND \"semaglutide\"[Title/Abstract]", "quotedPhrasesNotFound": [] }, "reportedCount": null } ], "finalQuery": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (semaglutide[tiab])", "finalCount": 1740, "createdAt": "2026-10-28T18:03:00.781Z" } ], "llmCalls": [], "events": [ { "seq": 1, "event": { "type": "stage", "stage": "parsing", "message": "Reading the numbered search lines" } }, { "seq": 2, "event": { "type": "lines", "lines": [ { "no": 1, "kind": "raw", "refs": [], "count": null, "query": "\"Diabetes Mellitus, Type 2\"[Mesh]", "issues": [], "display": "\"Diabetes Mellitus, Type 2\"[Mesh]", "reportedCount": null }, { "no": 2, "kind": "raw", "refs": [], "count": null, "query": "semaglutide[tiab]", "issues": [], "display": "semaglutide[tiab]", "reportedCount": null }, { "no": 3, "kind": "raw", "refs": [ 1, 2 ], "count": null, "query": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (semaglutide[tiab])", "issues": [], "display": "1 AND 2", "reportedCount": null } ] } }, { "seq": 3, "event": { "type": "stage", "stage": "validating_vocabulary", "message": "Checking 1 vocabulary term against NLM MeSH" } }, { "seq": 4, "event": { "type": "lines", "lines": [ { "no": 1, "kind": "raw", "refs": [], "count": null, "query": "\"Diabetes Mellitus, Type 2\"[Mesh]", "issues": [], "display": "\"Diabetes Mellitus, Type 2\"[Mesh]", "vocabulary": [ { "tag": "Mesh", "kind": "descriptor", "label": "Diabetes Mellitus, Type 2", "quoted": true, "validation": { "ui": "D003924", "label": "Diabetes Mellitus, Type 2", "status": "valid" } } ], "reportedCount": null }, { "no": 2, "kind": "raw", "refs": [], "count": null, "query": "semaglutide[tiab]", "issues": [], "display": "semaglutide[tiab]", "reportedCount": null }, { "no": 3, "kind": "raw", "refs": [ 1, 2 ], "count": null, "query": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (semaglutide[tiab])", "issues": [], "display": "1 AND 2", "reportedCount": null } ] } }, { "seq": 5, "event": { "type": "stage", "stage": "counting", "message": "Running 3 lines on PubMed" } }, { "seq": 6, "event": { "done": 1, "type": "progress", "total": 3, "message": "Line 1: 204,451 records" } }, { "seq": 7, "event": { "done": 2, "type": "progress", "total": 3, "message": "Line 3: 1,740 records" } }, { "seq": 8, "event": { "done": 3, "type": "progress", "total": 3, "message": "Line 2: 5,792 records" } }, { "seq": 9, "event": { "type": "lines", "lines": [ { "no": 1, "kind": "raw", "refs": [], "count": 204451, "query": "\"Diabetes Mellitus, Type 2\"[Mesh]", "issues": [], "display": "\"Diabetes Mellitus, Type 2\"[Mesh]", "countedAt": "2026-10-28T18:00:07.299Z", "vocabulary": [ { "tag": "Mesh", "kind": "descriptor", "label": "Diabetes Mellitus, Type 2", "quoted": true, "validation": { "ui": "D003924", "label": "Diabetes Mellitus, Type 2", "status": "valid" } } ], "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms]", "quotedPhrasesNotFound": [] }, "reportedCount": null }, { "no": 2, "kind": "raw", "refs": [], "count": 5792, "query": "semaglutide[tiab]", "issues": [], "display": "semaglutide[tiab]", "countedAt": "2026-10-28T18:02:58.002Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"semaglutide\"[Title/Abstract]", "quotedPhrasesNotFound": [] }, "reportedCount": null }, { "no": 3, "kind": "raw", "refs": [ 1, 2 ], "count": 1740, "query": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (semaglutide[tiab])", "issues": [], "display": "1 AND 2", "countedAt": "2026-10-28T18:02:57.690Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms] AND \"semaglutide\"[Title/Abstract]", "quotedPhrasesNotFound": [] }, "reportedCount": null } ] } }, { "seq": 10, "event": { "type": "stage", "stage": "fetching_records", "message": "Fetching the first 20 records of line 3" } }, { "seq": 11, "event": { "type": "records", "total": 1740, "records": [ { "pmid": "42947001", "year": "2026", "title": "Comparison of cardiac adverse event signal profiles for GLP-1 receptor agonists: an analysis of the FAERS database.", "authors": "Yildirim BO, Sarkim IF, Yalman G et al.", "journal": "BMC cardiovascular disorders", "publicationTypes": [ "Journal Article", "Comparative Study" ] }, { "pmid": "42946127", "year": "2026", "title": "Semaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance.", "authors": "Melamed B, Parsi-Zahabi M, Omrani MA et al.", "journal": "Pharmacoepidemiology and drug safety", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42937793", "year": "2026", "title": "Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): A systematic review and meta-analysis.", "authors": "Alfawaz M, Bajamaan D, Alghamdi L et al.", "journal": "Medicine", "publicationTypes": [ "Journal Article", "Systematic Review", "Meta-Analysis" ] }, { "pmid": "42918905", "year": "2026", "title": "GLP-1-based therapies in cardiovascular disease: outcomes, mechanisms, and emerging clinical applications.", "authors": "Jang R, Jang M, Ruan X et al.", "journal": "European journal of clinical pharmacology", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42905300", "year": "2026", "title": "Decoding the Safety Profile of GLP-1 Receptor Agonists: Facts, Myths, and Ongoing Controversies.", "authors": "Kounatidis DC, Vallianou NG, Kouveletsou M et al.", "journal": "Current obesity reports", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42899606", "year": "2026", "title": "Effectiveness of Weekly Semaglutide Treatment (0.5 or 1 mg) in Chilean Patients with Type 2 Diabetes Mellitus.", "authors": "Estica M, Godoy G, Vargas C et al.", "journal": "Revista medica de Chile", "publicationTypes": [ "Journal Article", "Multicenter Study", "Clinical Trial, Phase IV" ] }, { "pmid": "42890523", "year": "2026", "title": "CagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis.", "authors": "Rasool ZK, Shah R, Batool AEZ et al.", "journal": "Frontiers in endocrinology", "publicationTypes": [ "Journal Article", "Systematic Review", "Meta-Analysis" ] }, { "pmid": "42886550", "year": "2026", "title": "Pharmacy students' knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study.", "authors": "Khojah AA, Gazzaz MJ, Aldurdunji MM et al.", "journal": "The Libyan journal of medicine", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42885796", "year": "2026", "title": "Glucagon-Like Peptide-1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity.", "authors": "Governor SB, Dávila-García DM, Rivera-Segarra E et al.", "journal": "Journal of the American Heart Association", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42866418", "year": "2026", "title": "Values, preferences, and treatment burden for initiation of GLP-1 receptor agonists, SGLT-2 inhibitors, tirzepatide, and finerenone in adults with type 2 diabetes: systematic review.", "authors": "González-Cruz DC, Garcia-Campa M, Moreno-Peña PJ et al.", "journal": "BMJ medicine", "publicationTypes": [ "Journal Article", "Systematic Review" ] }, { "pmid": "42865361", "year": "2026", "title": "Pancreatic and biliary safety signals of GLP-1 receptor agonists and tirzepatide: a disproportionality analysis of FAERS reports.", "authors": "Wu Y, Li K, Wang Y et al.", "journal": "Frontiers in endocrinology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42859665", "year": "2026", "title": "Severe Euglycemic Diabetic Ketoacidosis After Semaglutide-Associated Poor Intake Despite Empagliflozin Discontinuation: A Case Report.", "authors": "Niknam K, Niknam T", "journal": "International medical case reports journal", "publicationTypes": [ "Case Reports", "Journal Article" ] }, { "pmid": "42854065", "year": "2026", "title": "Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease.", "authors": "Gong C, Luo Q, Li Q", "journal": "Medicine", "publicationTypes": [ "Journal Article", "Observational Study" ] }, { "pmid": "42827168", "year": "2026", "title": "Comorbid Cardiovascular-Liver Disease Disparities: Current Understanding and Future Directions.", "authors": "Hafez A, Nour M, Ibrahim R et al.", "journal": "Current cardiology reports", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42824923", "year": "2026", "title": "Predictors of treatment response to semaglutide for weight management.", "authors": "Tzoulis P", "journal": "Frontiers in endocrinology", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42823110", "year": "2026", "title": "Tirzepatide safety in EudraVigilance: descriptive and disproportionality analysis of preferred terms related to suboptimal treatment outcomes and drug-use-related issues.", "authors": "Popa Ilie IR, Ghibu S, Butuca A et al.", "journal": "BMJ open", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42808923", "year": "2026", "title": "Gastrointestinal adverse effects of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists: A narrative expert review of approved therapies, oral formulations, and pipeline agents.", "authors": "Singhani V, Ehsan M, Valencia S et al.", "journal": "Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42808550", "year": "2026", "title": "Real-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes.", "authors": "Hoog MM, Vallarino C, Maldonado JM et al.", "journal": "Journal of managed care & specialty pharmacy", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42802824", "year": "2026", "title": "Dapagliflozin Alone or Combined With Semaglutide: Cardiovascular and Renal Outcomes Among Patients With Type 2 Diabetes Mellitus in a 6-Month Real-World Retrospective Cohort Study in Saudi Arabia.", "authors": "Alharajin R, AlTaweel M, AlSubaiee M et al.", "journal": "Journal of the ASEAN Federation of Endocrine Societies", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42796421", "year": "2026", "title": "Clinical Profile of Documented Diabetic Peripheral Neuropathy by GLP-1-Based Medication Status: A Cross-Sectional Study.", "authors": "Ferician AC, Ghitea TC, Popoviciu MS", "journal": "Medicina (Kaunas, Lithuania)", "publicationTypes": [ "Journal Article" ] } ] } }, { "seq": 12, "event": { "type": "stage", "stage": "saving", "message": "Saving the run" } }, { "seq": 13, "event": { "type": "done", "finalCount": 1740 } } ] }